British American Tobacco Plc (BAT) operates in all four Index Regions, and in 34 of the 36 Index Countries. Its top five countries by Volume Sales are the USA, Bangladesh, Russia, Pakistan, and Brazil.
BAT operates across HMICs (23 Index Countries) and LMICs (11 Index Countries).
BAT’s product portfolio consists of cigarettes, fine cut tobacco, moist snuff, heated tobacco, cigarillos, e-liquids, closed system vaping products, snus, non-tobacco nicotine pouches, chewing tobacco, pipe tobacco, and NRT products (non-patches).
"Our purpose of building A Better Tomorrow by reducing the health impact of our business means that we are committed to our business transformation...As consumer preferences and technology rapidly evolve, the availability of scientifically-substantiated, less risky products is crucial to effective tobacco harm reduction and we are determined to transform our business.”
(Jack Bowles, CEO, BAT Annual Report 2021).
BAT’s global Volume Sales of HRPs (in particular cigarettes) declined in 2019-2021 (CAGR: -1.2%). RRP Volume Sales increased (CAGR: +14.9%), driven in particular by its Vuse closed system vaping product in the USA, and Velo non-tobacco nicotine pouches globally.
BAT expanded its RRP portfolio in 2020 through the acquisition of Dryft Sciences LLC’s non-tobacco nicotine pouch product assets.
BAT increased its score in the Strategy and Management category, by further clarifying its remuneration policy in 2021, disclosing the specific amount (15%) linked to RRP performance.
ppts = Difference in percentage between 2021 and 2019
To search, type what you're looking for and results will appear automatically